Medicaments composite for qi stagnation type breast hyperplasia and preparation method thereof

A breast hyperplasia and qi stagnation type technology, which is applied in the direction of drug combination, pharmaceutical formula, medical preparations containing active ingredients, etc., can solve the problem of high incidence

Inactive Publication Date: 2008-10-08
BEIJING ZHONGTAI TIANHE SCI & TECH
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although there is no general and specific survey in this regard, judging from the physical examination clinics of the hospital, women with breast hyperplasia can account for 70% to 90% of all women who come for examination. From this point of view, the incidence rate is quite high of

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Embodiment 1: the preparation method of granule

[0034] 1. Prescription:

[0035] 160 parts of angelica, 120 parts of melon, 120 parts of frankincense

[0036] 160 parts of myrrh, 120 parts of licorice, 60 parts of orange core

[0037] 160 parts of saponin thorn, 120 parts of ground beetle, 60 parts of mugwort leaves

[0038] 160 parts of Wang Buliuxing, 160 parts of malt, and 160 parts of Milletah

[0039] 120 parts of Sanchaku, 120 parts of Forsythia, 120 parts of Gongluomu

[0040] Smilax cocos 160 parts

[0041] 2. Preparation process

[0042] (1) Angelica, Trichosanthes, frankincense, myrrh, licorice, orange core, saponins, ground beetle, mugwort leaves, buliuxing, malt, spatholobus, three-fork bitter, forsythia, gongluomu, smilax Add water and decoct twice, the first time for 2 hours, the second time for 1.5 hours, filter, combine the filtrate, and concentrate the filtrate into a clear paste with a relative density of 1.08-1.14 (50-60°C), add 2.8 times the ...

Embodiment 2

[0044] Embodiment 2: the preparation method of tablet

[0045] 1. Prescription:

[0046] 160 parts of angelica, 120 parts of melon, 120 parts of frankincense

[0047] 160 parts of myrrh, 120 parts of licorice, 60 parts of orange core

[0048] 160 parts of saponin thorn, 120 parts of ground beetle, 60 parts of mugwort leaves

[0049] 160 parts of Wang Buliuxing, 160 parts of malt, and 160 parts of Milletah

[0050] 120 parts of Sanchaku, 120 parts of Forsythia, 120 parts of Gongluomu

[0051] Smilax cocos 160 parts

[0052] 2. Preparation process

[0053] (1) Angelica, Trichosanthes, frankincense, myrrh, licorice, orange core, saponins, ground beetle, mugwort leaves, buliuxing, malt, spatholobus, three-fork bitter, forsythia, gongluomu, and smilax Add water and decoct twice, the first time for 2 hours, the second time for 1.5 hours, filter, combine the filtrate, and concentrate the filtrate into a clear paste with a relative density of 1.08-1.14 (50-60°C), add 2.8 times t...

Embodiment 3

[0055] Embodiment 3: the preparation method of capsule

[0056] 1. Prescription:

[0057] 160 parts of angelica, 120 parts of melon, 120 parts of frankincense

[0058] 160 parts of myrrh, 120 parts of licorice, 60 parts of orange core

[0059] 160 parts of saponin thorn, 120 parts of ground beetle, 60 parts of mugwort leaves

[0060] 160 parts of Wang Buliuxing, 160 parts of malt, and 160 parts of Milletah

[0061] 120 parts of Sanchaku, 120 parts of Forsythia, 120 parts of Gongluomu

[0062] Smilax cocos 160 parts

[0063] 2. Preparation process

[0064] (1) Angelica, Trichosanthes, frankincense, myrrh, licorice, orange core, saponins, ground beetle, mugwort leaves, buliuxing, malt, spatholobus, three-fork bitter, forsythia, gongluomu, and smilax Add water and decoct twice, the first time for 2 hours, the second time for 1.5 hours, filter, combine the filtrate, and concentrate the filtrate into a clear paste with a relative density of 1.08-1.14 (50-60°C), add 2.8 times th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medical combination used for treating qi stagnation type mammary hyperplasia. The effective ingredients of the invention are extracted from more than ten drugs of roots of Chinese angelica, mongolian snakegourd, gum mastic, myrrh, liquorice, tangerine seed, stings of gleditsia sinensis lam, ground beetle, mugwort leaf, cowherb seed, malt, suberect spatholobus, Evodia lepta, fructus forsythiae, Chinese mahonia stem, glabrous greenbrier rhizome, etc. The special medical effective ingredients of the invention have the effects of nourishing blood and the liver, discharging the liver and regulating qi and used for treating breast caking and pain caused by mammary hyperplasia of a sufferer, premenstrual gloomy emotion, menstrual disorder or early onset of menstruation, and so on.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicine pharmacy, and in particular relates to a medicine combination for qi-stagnation mammary gland hyperplasia and a preparation method thereof. technical background [0002] Breast lobular hyperplasia is a chronic non-inflammatory disease of the breast. It is one of the frequently-occurring diseases of women. The incidence rate in urban areas is higher than that in rural areas, and it is common in young or middle-aged women. The pathogenesis of mammary gland hyperplasia is not yet fully clear, and it is mostly related to mental factors and endocrine disorders, especially ovarian dysfunction. Its clinical manifestations are round or oval nodules of various sizes on one or both breasts of the patient, which are tough but not hard, have no adhesion with the skin and deep tissues, and have no obvious borders and can be moved; There is often dull pain, distending pain or tingling in t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/899A61K9/16A61K9/20A61K9/48A61P15/14A61K35/56A61K35/64
Inventor 何俊保
Owner BEIJING ZHONGTAI TIANHE SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products